Arlington Capital Management’s FT Vest US Equity Enhance & Moderate Buffer ETF November XNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,012
Closed -$270K 106
2025
Q1
$270K Buy
8,012
+163
+2% +$5.58K 0.2% 58
2024
Q4
$267K Buy
7,849
+832
+12% +$28.3K 0.18% 70
2024
Q3
$236K Buy
7,017
+885
+14% +$29.5K 0.19% 70
2024
Q2
$203K Sell
6,132
-282
-4% -$9.2K 0.18% 85
2024
Q1
$208K Sell
6,414
-23
-0.4% -$734 0.17% 85
2023
Q4
$202K Buy
+6,437
New +$200K 0.18% 94

Other funds holding XNOV

Arlington Capital Management's XNOV Position: Q2 2025 in Review

Arlington Capital Management sold out of FT Vest US Equity Enhance & Moderate Buffer ETF November (XNOV) in Q2 2025, closing a stake of 8,012 shares — an estimated $270K sold.

Arlington Capital Management first reported a position in XNOV in Q4 2023 and held it in 6 quarters. The position peaked at $270K in Q1 2025. 22 funds tracked by Wall St. Rank hold XNOV as of Q2 2025.

  • Arlington Capital Management reported no remaining FT Vest US Equity Enhance & Moderate Buffer ETF November position as of Q2 2025 after selling out during the quarter.
  • Arlington Capital Management sold 8,012 FT Vest US Equity Enhance & Moderate Buffer ETF November shares in Q2 2025, an estimated $270K.
  • Arlington Capital Management first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF November in Q4 2023 and held it in 6 quarters.
  • Arlington Capital Management's FT Vest US Equity Enhance & Moderate Buffer ETF November position peaked at $270K in Q1 2025.
  • 22 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF November as of Q2 2025.

Based on Arlington Capital Management's 13F filing for Q2 2025, filed 16 Jul 2025.